SciELO - Scientific Electronic Library Online

 
vol.79 número5Tratamiento sistémico para dermatitis atópica grave en niños: una serie de casosHamartoma de músculo liso adquirido con componente sebáceo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Boletín médico del Hospital Infantil de México

versión impresa ISSN 1665-1146

Bol. Med. Hosp. Infant. Mex. vol.79 no.5 México sep./oct. 2022  Epub 31-Oct-2022

https://doi.org/10.24875/bmhim.22000008 

Research articles

Gut microbiota composition after a dietary and physical activity intervention: a pilot study in Mexican children with obesity

Efecto de una intervención nutricia y de actividad física sobre la composición de la microbiota intestinal: un estudio piloto en niños mexicanos con obesidad

Sofía Morán-Ramos1  2  3 

María T. Siliceo-Bernardi4 

Salvador Villalpando-Carrión4 

Samuel Canizales-Quinteros2  3 

María E. Frigolet5  * 

Ruth Gutiérrez-Aguilar5  6  * 

1Consejo Nacional de Ciencia y Tecnología, Mexico City, Mexico

2Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México

3Instituto Nacional de Medicina Genómica

4Departamento de Gastroenterología y Nutrición, Hospital Infantil de México Federico Gómez

5Laboratorio de Investigación en Enfermedades Metabólicas: Obesidad y Diabetes, Hospital Infantil de México Federico Gómez

6División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México. Mexico City, Mexico


Abstract

Background:

Gut microbiota is a complex organized collection of microorganisms that confers multiple metabolic advantages to the host. The reduced diversity and proportion of specific gut microbial species have been associated with obesity and metabolic disorders. Multidimensional interventions, including modifications in dietary and physical activity habits, are associated with favorable changes in microbiota composition. This pilot study aimed to evaluate changes in the gut microbiota composition of Mexican children with obesity before and after a 6-week multidimensional intervention.

Methods:

Blood and stool samples were collected, and anthropometric measurements were obtained from six children with obesity before and after the intervention. The intervention consisted of modeling a hypo energetic diet and giving nutritional and physical activation recommendations. DNA from stool samples was used to characterize gut microbial composition by sequencing the 16S rRNA gene.

Results:

The decrease in waist circumference was associated with increased Odoribacter relative abundance. However, gut microbiota composition and diversity remained unchanged.

Conclusions:

Although no modifications in the body mass index, body fat, composition, or diversity of the gut microbiota were observed with the intervention, it was possible to associate the reduction in waist circumference with the presence of Odoribacter after a multidimensional intervention in Mexican children with obesity.

Keywords Obesity; Gut microbiota; Dietary intervention; Physical activity

Resumen

Introducción:

La microbiota intestinal es un conjunto de microorganismos organizados de forma compleja que confieren múltiples ventajas metabólicas al hospedero. La reducida diversidad y la proporción de ciertas especies sobre otras se ha asociado con obesidad y enfermedades metabólicas. Las intervenciones multidimensionales, que incluyen modificaciones en los hábitos alimentarios y de actividad física, se asocian con cambios favorables en la composición de la microbiota. El objetivo de este estudio piloto fue evaluar la composición de la microbiota intestinal de niños mexicanos con obesidad, antes y después de una intervención multidimensional de seis semanas de duración.

Métodos:

Se tomaron muestras de sangre y de heces y se realizaron las mediciones antropométricas de seis niños con obesidad, antes y después de la intervención. La intervención consistió en modelar una dieta hipoenergética y dar recomendaciones nutricias y de actividad física. A partir del DNA de las muestras de heces se realizó la caracterización de la microbiota intestinal por secuenciación del gen 16S del RNAr.

Resultados:

La disminución de la circunferencia de cintura se asoció con un aumento en la abundancia del género Odoribacter. Sin embargo, no se encontraron cambios en la composición de la microbiota intestinal.

Conclusiones:

A pesar de que la intervención no modificó el índice de masa corporal, masa grasa, composición ni diversidad de la microbiota intestinal, sí se logró asociar la reducción de la circunferencia de cintura con la abundancia de Odoribacter en el presente estudio piloto en niños mexicanos con obesidad.

Palabras clave Obesidad; Microbiota intestinal; Intervención nutricia; Actividad física

Introduction

The gut microbiota is a set of microorganisms colonizing the digestive tract. It is a highly complex ecosystem, harboring large bacterial populations in the intestine and colon, with approximately 1011-1012 microorganisms/g of intestinal contents1. Microbes detected in the human intestinal tract can be classified into three domains based on molecular phylogeny: Eukarya, Bacteria, and Archaea. Bacteria are the predominant strains of the gut microbiota. Around 90% of fecal bacteria belong to two major phylogenetic lineages: Firmicutes and Bacteroidetes. However, the gastrointestinal tract of adult humans has been estimated to contain approximately 500 to 1000 different bacterial species2. The number and proportion of particular bacterial species in the intestinal tract are known as microbiota diversity, which is associated with the versatility of metabolic functions3.

The first years of life are a crucial stage for gut microbiota development. Colonization of the digestive tract begins at birth4. Subsequently, infant feeding and weaning are essential for gut microbiota development and further establishment during adulthood. While some groups have claimed that gut microbiota remains relatively stable after infancy5,6, others have demonstrated continued microbial plasticity during childhood and adolescence7-9. However, functional features of microbiota in children/adolescents may change at this stage of life, and gut microbiota may develop more gradually than previously proposed7. Thus, lifestyle changes at this stage still represent an opportunity for modifying microbiota composition.

Recently, changes in the bacterial composition of the human intestine were proposed to play a causal role in obesity10-12. It has been shown that individuals with obesity have less bacterial number and diversity than healthy individuals. In Mexican children with obesity, an increased amount of Bacteroides eggerthii was found, which correlated positively with body fat percentage13. Other studies have shown an increase in Prevotella or Collinsella in Mexican children and adolescents with obesity14,15.

In animal models of diet-induced obesity, reduced gut microbiota diversity and changes in mucosal integrity have been associated with increased permeability, pathogen translocation, and inflammation16,17. Interestingly, some of these modifications are reversible when high-fat intake or the dietary factor causing obesity is discontinued18.

Dietary interventions in adults and children generate modifications in the composition and diversity of gut microbiota19-21. Moreover, physical activation induces an increased number of short-chain fatty acid-producing species22, contributing to a healthy state23. Regardless of diet, exercise promotes intestinal balance and improvement in gut microbiota composition, with consequent favorable metabolic changes in children24. Childhood obesity interventions have been shown to affect weight loss when lifestyle changes are achieved25. The most effective multidimensional interventions promote changes in food consumption patterns, physical activation, and behavior26,27. At the Hospital Infantil de México Federico Gómez (HIMFG), the Pediatric Obesity Clinic has been designed to promote nutritional and physical activity behavioral modifications. No previous publication has reported whether the gut microbiota composition of Mexican children with obesity changes after a multidimensional intervention. The present pilot study aimed to evaluate modifications in the gut microbiota composition of Mexican children with obesity driven by a 6-week multifaceted intervention.

Methods

Study design

We conducted a short-term, quasi-experimental, longitudinal pilot study to compare the microbiota composition of obese children before and after 6 weeks of dietary and physical activity measures.

Participants

Children were selected from the Dynamic Child Care for Obesity and Overweight Program (PAIDOS, for its Spanish acronym) of the Pediatric Obesity Clinic, Hospital Infantil de México Federico Gómez (HIMFG). The study was approved by the Ethics Committee (HIM/2019/010), and parents and participants provided written informed consent and assent, respectively.

As inclusion criteria, we considered those participants living in the Mexico City area and following a 6-week diet and physical activity intervention (short-term), with no neurological or psychomotor disorders or obesity-causing diseases. Patients with diarrhea or antibiotic exposure 3 months before the study were excluded. Although we initially recruited 20 children with obesity, only nine patients donated both (pre- and post-intervention) self-collected stool samples. Three of these nine patients were excluded due to antibiotics intake during the intervention. Therefore, only six male children with obesity (aged 11-14 years) participated in this study. In addition, fasting blood samples (pre- and post-intervention) were collected for biochemical analyses and anthropometric measurements.

Anthropometric parameters

Anthropometric measurements included weight, height, and waist circumference. Body fat mass percentage was obtained by bioelectrical impedance analysis (TANITA, BF-689). Obesity status was defined as a zBMI score > 1.6428,29 or as a body fat percentage > 32 for males30.

Blood sampling and biochemical analyses

Blood samples were drawn after 12 h fasting, and serum was separated using gel separation tubes. Serum levels of glucose, total cholesterol, HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), triglycerides, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were quantified with commercially available standardized methods (Dimension RXL Max, ®).

Multidimensional intervention: diet, nutrition education, and physical activity intervention

Patients visited the Pediatric Obesity Clinic weekly for six weeks. In the first session, medical history, as well as anthropometric and dietary information, was obtained. In addition, participants received a hypo energetic dietary plan (60% energy from carbohydrates, 20-25% from fats, and 15-20% from proteins) and instructions according to their age, gender, and a moderate to intense physical activity plan. In subsequent sessions, anthropometric measurements were conducted. Patients also received nutritional education and physical activation recommendations to achieve at least 150 min/week. The objectives of nutritional education were to increase fruit and vegetable consumption, replace refined carbohydrates with whole grains, and limit the consumption of sugar added to processed food and sugar-sweetened beverages. After six weeks, anthropometric and biochemical data were again determined for comparison (pre- and post-intervention data).

Stool sampling and DNA extraction

Pre- and post-intervention fecal samples were self-collected at home in a sterile cup and refrigerated overnight before storage at −80°C until processing. DNA was extracted from 200 mg of feces using the QIAamp® DNA Stool Mini Kit (Qiagen, Inc.). DNA concentration was determined spectrophotometrically.

Sequencing of 16S rRNA

Characterization of the gut microbiome was performed by sequencing the V4 hypervariable region of the 16S rRNA, using primers 515F and 806R, as suggested by the Earth Microbiome Project and as previously described13. Briefly, PCR was performed on 100 ng DNA. Products were purified using Agencourt AMPure XP beads (Beckman Coulter) with an automated protocol in the Agilent Bravo Automated Liquid Handling Platform (Agilent Technologies). Equimolar ratios of amplicons from the individual samples were pooled and sequenced using an Illumina MiSeq 2 × 250 platform. The size and concentration of each sequencing pool were determined by an Agilent D1000 ScreenTape for TapeStation 4200 system (Agilent Technologies) and a Qubit 2.0 fluorometer (Invitrogen), respectively.

Data processing and statistical analysis

Sequences were analyzed using QIIME 1.9.0. Quality filters removed sequences containing mismatched barcodes, ambiguous bases, or low-quality reads (Phred quality score < 30). After trimming barcodes, demultiplexing was performed. Operational taxonomic unit (OTU) read counts were obtained with a closed-reference OTU selection algorithm at 97% identity against the Greengenes database (version 13_08). Potential chimeras were detected with USearch61 and excluded from further analysis. Taxonomic classification was performed to generate phylum to genus level composition matrices. Alpha and beta diversity statistics were calculated with QIIME31.

Statistical analysis was performed with R and SPSS. Data normality was assessed with Kolmogorov-Smirnov test. Data are shown as median and interquartile ranges for continuous variables or percentages for categorical variables. Paired Wilcoxon tests assessed differences in metabolic traits pre-and post-intervention. Ordination was performed by principal coordinates analysis (PCoA) on weighted and unweighted Unifrac dissimilarities for gut microbiota composition. Rarefaction curves were calculated by QIIME, with subsampling in the range of 10-58,000 sequences, with one step of 1,000 sequences and ten re-samplings on each step. Values were obtained for the Shannon diversity index, observed OTUs, and Chao1 richness estimation at a standardized sequencing depth. Differences in bacterial community composition were evaluated by PERMANOVA using Unifrac distances. For taxonomic characterization, OTUs whose mean abundance in all samples was < 0.01% were excluded. The paired Wilcoxon test evaluated alpha diversity and taxonomic differences pre-and post-intervention. Spearman correlations tests were performed to relate taxa abundances to changes in metabolic traits (delta waist circumference: T6–T0). Statistical significance was considered when p < 0.05.

Results

Anthropometric and biochemical parameters

Only nine of the 20 children initially recruited provided pre- and post-intervention stool samples. Three of these nine patients were excluded due to antibiotic use. Therefore, six male participants met the inclusion criteria, completed the program, and provided pre- and post-intervention samples. Most anthropometric and biochemical characteristics did not change after the intervention (Table 1). However, waist circumference was significantly reduced after the intervention (98.05 ± 11.2 cm pre- vs. 94.95 ± 7.82 cm post-intervention, p = 0.031).

Table 1 Clinical and biochemical variables of the studied population 

Variables Median IQR
Age (y) 12.915 2
Height (m) 1.602 0.13725
Pre-intervention Post-intervention p- value
Median IQR Median IQR
Waist circumference (cm) 98.05 11.20 94.95 7.82 0.03*
Weight 71.80 17.05 71.85 14.52 0.84
BMI Z-score 1.87 0.22 1.87 0.22 0.59
Body fat (%) 32.95 4.17 30 3.90 0.09
Glucose (mg/dL) 87 5.25 91.50 12.75 0.28
Total cholesterol (mg/dL) 150.50 47.25 155.50 26.25 1
HDL-C (mg/dL) 39.50 6.75 37 5 0.36
LDL-C (mg/dL) 85.20 41.35 91.50 6.30 0.59
TG(mg/dL) 94.50 85.50 122 109.50 0.79
ALT (mg/dL) 36 11.50 35 10.50 0.17
AST (mg/dL) 22 4.25 26.50 3.25 0.89

All participants were male (n = 6). Data are expressed as medians, IQR, Wilcoxon paired test,

*p < 0.05.

ALT: alanine aminotransferase; AST: aspartate aminotransferase;

BMI Z-score: body mass index Z-score; HDL-C: high-density lipoprotein cholesterol; IQR: interquartile range; LDL-C: low-density lipoprotein cholesterol;

TG: triglycerides.

Gut microbiota richness and diversity

Fecal DNA sequencing resulted in a mean number of sequences per sample of 87,602 (range 58,363–115,770). Observed OTUs, Chao estimate of richness, and Shannon index showed no significant differences pre-post-intervention (Figure 1). Moreover, in the PCoA of unweighted and weighted Unifrac distances, samples were not clustered pre- or post-intervention (Figures 1D and E). PERMANOVA analyses of distance matrices showed no significant effect of the intervention on overall community composition. In contrast, individuals showed a statistically significant proportion of gut microbial variation (unweighted, R2 = 0.52, p = 9.9 x 10-3 and weighted, R2 = 0.70, p = 0.020), suggesting that the gut bacterial composition of children with obesity was given by individual divergence, but not by diet or physical activation during the time of the intervention.

Figure 1 Alpha and beta diversity plots pre-and post-intervention. A: observed OTUs, B: Chao estimate, and C. Shannon index pre- and post-intervention in children with obesity. D-E: principal coordinates analysis of samples pre- and post-intervention based on D. unweighted Unifrac distance and E. weighted Unifrac distance (n = 6). Paired Wilcoxon tests evaluated differences in alpha diversity indexes pre-and post-intervention. 

Phylum and family distribution

We next evaluated the composition of the gut microbiota at the phylum level. The most abundant phylum in children before the intervention was Bacteroidetes (median relative abundance = 46.5%), followed by Firmicutes (median relative abundance = 45.7%), and Proteobacteria (median relative abundance = 3.7%) (Figure 2A), and no significant modifications in this abundance were observed after the intervention. No significant differences were found at the family or genus level (Figure 2B) (Supplementary table 1). These results indicate that this multidimensional intervention showed no consistent effect on the gut microbial composition of individuals.

Figure 2 Taxonomic classification of fecal samples pre-and post-intervention. A: stacked bar chart of the phylum-level classification of intestinal bacteria by relative abundance. B: stacked bar chart of the genera whose mean relative abundance was >1%; genera below these levels were collapsed in “Other.” Bars represent individual samples (n = 6). Paired Wilcoxon tests evaluated differences in taxa relative abundance pre-and post-intervention. B: before; A: after. 

Correlation between anthropometric data and taxonomic abundance modifications

Spearman correlations were performed to test whether gut microbiota changes post-intervention were related to the observed changes in waist circumference. At the genus level, Odoribacter abundance showed a negative and significant correlation with the change in waist circumference (delta waist circumference T6-T0) (Figure 3): the quantity of Odoribacter increased significantly in those with a more substantial reduction in waist circumference (r = -0.94, p = 0.0167). Correlation tests between changes in waist circumference and taxa abundance are shown in Supplementary table 2.

Figure 3 Correlation between changes in waist circumference and Odoribacter relative abundance after a multidimensional intervention in children with obesity (n = 6); rho and p-value are based on Spearman’s rank correlation. Delta waist circumference was calculated as time at 6 weeks minus time at the beginning of intervention (T6 - T0) 

Discussion

Comprehensive treatment with lifestyle modifications that lead to weight loss is essential to reduce the high rates of childhood obesity. Lifestyle modifications that include diet, behavioral treatment, and physical activity (i.e., multidimensional interventions) have been extensively studied due to their effects on weight loss, BMI reduction, and adiposity indicators32. In addition, improvements in weight loss, diastolic/systolic blood pressure, oxidative status, and some biochemical parameters associated with metabolic syndrome are frequently observed33. However, inconsistent results have been found for serum glucose and lipid concentrations34,35. These differences generally depend on the type of dietary treatments, distribution of nutrients, and the timing of the interventions (short- versus long-term).

Six subjects who met the inclusion criteria were recruited for this pilot study. The intervention lasted six weeks, during which the participants received a hypo energetic and individualized dietary plan without modifying the standard macronutrient distribution. In addition, patients received nutritional education and physical activation recommendations to achieve at least 150 min/week.

Regarding adiposity, we observed that the intervention reduced waist circumference without modifying BMI or body fat. These results were unexpected, as BMI and body fat are adiposity indicators. It is possible that 6 weeks of multidimensional intervention produced initial modifications in waist circumference, which correlates with the amount of visceral fat36. Still, it was not long enough to modify other anthropometric measurements further. A review study showed that long-term interventions in Mexican children based in Mexico or the United States changed adiposity markers when nutrition and physical activity were modified37. A 12-week physical activity intervention in Mexican children did not modify BMI but decreased biochemical parameters such as blood glucose and cholesterol concentrations38. Therefore, a long-term multidimensional intervention that includes a more significant number of children could better impact the Mexican population in the future.

Few dietary interventions have demonstrated a beneficial influence on the composition of the gut microbiota of children with obesity16,39,40. The effects of a multidimensional intervention (diet, nutritional education, and physical activity) on the gut microbiota of Mexican children with obesity have not been investigated in depth. The present pilot study found that gut microbiota composition and diversity were not modified after this intervention. This result was unexpected, as we hypothesized that the multidimensional intervention would change gut microbiota composition. However, this pilot study was designed to describe our findings during an initial approach with patients, which is valuable for our following contributions with larger sample sizes.

Although no modifications were found in the overall composition of the microbiota, an interesting finding was that the relative abundance of Odoribacter was correlated with the change in waist circumference: as waist circumference decreased, Odoribacter abundance increased. Previous studies in children and adolescents have associated Odoribacter with adiposity. Odoribacter was inversely correlated with visceral and subcutaneous adipose tissue and intrahepatic lipid deposition41. Moreover, Odoribacter abundance has also been related to metabolic health. Obese and overweight children and adults were classified into metabolically healthy and unhealthy, concluding that Odoribacter abundance was higher in healthy subjects42,43. Therefore, our results are consistent with previous studies indicating that Odoribacter abundance is associated with adiposity indicators and metabolic status.

However, as mentioned, an additional cohort and a more extended intervention are needed to confirm these results in our population. To further determine whether Odoribacter abundance is related to metabolic health, we need to include lean children and children with obesity, healthy children, and those with metabolic diseases to explore microbiota composition focusing on Odoribacter and following lifestyle change interventions.

Limitations of the study

For this pilot study, our group recruited 20 individuals who agreed to participate in the intervention; however, after adjusting for inclusion and exclusion criteria, the final sample size (n = 6) was small. The findings of this pilot study should be confirmed in a larger sample. Additionally, a long-term intervention could drive further anthropometric modifications to reflect gut microbiota composition and diversity changes. Therefore, a larger sample size and a more extended intervention are needed to confirm these results and investigate whether further gut microbiota modifications could be observed.

In this short-term pilot study, although no changes in BMI, body fat, gut microbiota composition, or diversity were observed with the intervention, waist circumference reduction was inversely associated with the abundance of Odoribacter after a multidimensional intervention in Mexican children with obesity.

Supplementary data

Supplementary data are available at Boletín Médico del Hospital Infantil de México online (https://10.24875/BMHIM.22000008). These data are provided by the corresponding author and published online for the benefit of the reader. The contents of supplementary data are the sole responsibility of the authors.

REFERENCES

1. Preveden T, Scarpellini E, Milic N, Luzza F, Abenavoli L. Gut microbiota changes and chronic hepatitis C virus infection. Expert Rev Gastroenterol Hepatol. 2017;11:813-9. [ Links ]

2. Nash AK, Auchtung TA, Wong MC, Smith DP, Gesell JR, Ross MC, et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 2017;5:153. [ Links ]

3. Lozupone CA, Knight R. Species divergence and the measurement of microbial diversity. FEMS Microbiol Rev. 2008;32:557-78. [ Links ]

4. Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int. 2017;66:515-22. [ Links ]

5. Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690-703. [ Links ]

6. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222-7. [ Links ]

7. Hollister EB, Riehle K, Luna RA, Weidler EM, Rubio-Gonzales M, Mistretta TA, et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome. 2015;3:36. [ Links ]

8. Agans R, Rigsbee L, Kenche H, Michail S, Khamis HJ, Paliy O. Distal gut microbiota of adolescent children is different from that of adults. FEMS Microbiol Ecol. 2011;77:404-12. [ Links ]

9. Ringel-Kulka T, Cheng J, Ringel Y, Salojarvi J, Carroll I, Palva A, et al. Intestinal microbiota in healthy U.S. young children and adults—a high throughput microarray analysis. PloS one. 2013;8:e64315. [ Links ]

10. Castaner O, Goday A, Park YM, Lee SH, Magkos F, Shiow STE, et al. The gut microbiome profile in obesity:a systematic review. Int J Endocrinol. 2018;2018:4095789. [ Links ]

11. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014;20:16079-94. [ Links ]

12. Kobyliak N, Virchenko O, Falalyeyeva T. Pathophysiological role of host microbiota in the development of obesity. Nutr J. 2016;15:43. [ Links ]

13. Lopez-Contreras BE, Moran-Ramos S, Villarruel-Vazquez R, Macias-Kauffer L, Villamil-Ramirez H, Leon-Mimila P, et al. Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits. Pediatr Obes. 2018;13:381-8. [ Links ]

14. Maya-Lucas O, Murugesan S, Nirmalkar K, Alcaraz LD, Hoyo-Vadillo C, Pizano-Zarate ML, et al. The gut microbiome of Mexican children affected by obesity. Anaerobe. 2019;55:11-23. [ Links ]

15. Nirmalkar K, Murugesan S, Pizano-Zarate ML, Villalobos-Flores LE, Garcia-Gonzalez C, Morales-Hernandez RM, et al. Gut microbiota and endothelial dysfunction markers in obese mexican children and adolescents. Nutrients. 2018;10:2009. [ Links ]

16. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2010;4:232-41. [ Links ]

17. Ji Y, Sakata Y, Tso P. Nutrient-induced inflammation in the intestine. Curr Opin Clin Nutr Metab Care. 2011;14:315-21. [ Links ]

18. Shang Y, Khafipour E, Derakhshani H, Sarna LK, Woo CW, Siow YL, et al. Short term high fat diet induces obesity-enhancing changes in mouse gut microbiota that are partially reversed by cessation of the high fat diet. Lipids. 2017;52:499-511. [ Links ]

19. Vandeputte D, Falony G, Vieira-Silva S, Wang J, Sailer M, Theis S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut. 2017;66:1968-74. [ Links ]

20. Huang J, Liao J, Fang Y, Deng H, Yin H, Shen B, et al. Six-week exercise training with dietary restriction improves central hemodynamics associated with altered gut microbiota in adolescents with obesity. Front Endocrinol. 2020;11:569085. [ Links ]

21. Leal-Witt MJ, Llobet M, Samino S, Castellano P, Cuadras D, Jimenez-Chillaron JC, et al. Lifestyle intervention decreases urine trimethylamine n-oxide levels in prepubertal children with obesity. Obesity. 2018;26:1603-10. [ Links ]

22. Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018;50:747-57. [ Links ]

23. Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev. 2017;2017:3831972. [ Links ]

24. Quiroga R, Nistal E, Estebanez B, Porras D, Juarez-Fernandez M, Martinez-Florez S, et al. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Exp Mol Med. 2020;52:1048-61. [ Links ]

25. Lobstein T, Baur L, Uauy R, TaskForce IIO. Obesity in children and young people:a crisis in public health. Obes Rev. 2004;5 Suppl 1:4-104. [ Links ]

26. Oude Luttikhuis H, Baur L, Jansen H, Shrewsbury VA, O'Malley C, Stolk RP, et al. Interventions for treating obesity in children. Cochrane Database Syst Rev. 2009:CD001872. [ Links ]

27. Wang JJ, Lau WC, Wang HJ, Ma J. Evaluation of a comprehensive intervention with a behavioural modification strategy for childhood obesity prevention:a nonrandomized cluster controlled trial. BMC Public Health. 2015;15:1206. [ Links ]

28. Barlow SE, Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity:summary report. Pediatrics. 2007;120 Suppl 4:S164-92. [ Links ]

29. Centers for Disease Control and Prevention. Childhood Obesity Facts. Atlanta:Centers for Disease Control and Prevention;2021. Available from:https://www.cdc.gov/obesity/data/childhood.html. [ Links ]

30. McCarthy HD, Cole TJ, Fry T, Jebb SA, Prentice AM. Body fat reference curves for children. Int J Obes (Lond). 2006;30:598-602. [ Links ]

31. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335-6. [ Links ]

32. Albert Perez E, Mateu Olivares V, Martinez-Espinosa RM, Molina Vila MD, Reig Garcia-Galbis M. New insights about how to make an intervention in children and adolescents with metabolic syndrome:diet, exercise vs. changes in body composition. A systematic review of RCT. Nutrients. 2018;10:878. [ Links ]

33. Ho M, Garnett SP, Baur L, Burrows T, Stewart L, Neve M, et al. Effectiveness of lifestyle interventions in child obesity:systematic review with meta-analysis. Pediatrics. 2012;130:e1647-71. [ Links ]

34. O'Connor EA, Evans CV, Burda BU, Walsh ES, Eder M, Lozano P. Screening for obesity and intervention for weight management in children and adolescents:evidence report and systematic review for the us preventive services task force. JAMA. 2017;317:2427-44. [ Links ]

35. Rajjo T, Almasri J, Al Nofal A, Farah W, Alsawas M, Ahmed AT, et al. The association of weight loss and cardiometabolic outcomes in obese children:systematic review and meta-regression. J Clin Endocrinol Metab. 2017;102:758-62. [ Links ]

36. Ness-Abramof R, Apovian CM. Waist circumference measurement in clinical practice. Nutr Clin Pract. 2008;23:397-404. [ Links ]

37. Eisenberg CM, Sanchez-Romero LM, Rivera-Dommarco JA, Holub CK, Arredondo EM, Elder JP, et al. Interventions to increase physical activity and healthy eating among overweight and obese children in Mexico. Salud Publica Mex. 2013;55:441-6. [ Links ]

38. Polo-Oteyza E, Ancira-Moreno M, Rosel-Pech C, Sanchez-Mendoza MT, Salinas-Martinez V, Vadillo-Ortega F. An intervention to promote physical activity in Mexican elementary school students:building public policy to prevent noncommunicable diseases. Nutr Rev. 2017;75:70-8. [ Links ]

39. Hollister EB, Foster BA, Dahdouli M, Ramirez J, Lai Z. Characterization of the stool microbiome in hispanic preschool children by weight status and time. Child Obes. 2018;14:122-30. [ Links ]

40. Nagata S, Chiba Y, Wang C, Yamashiro Y. The effects of the Lactobacillus casei strain on obesity in children:a pilot study. Benef Microbes. 2017;8:535-43. [ Links ]

41. Goffredo M, Mass K, Parks EJ, Wagner DA, McClure EA, Graf J, et al. Role of gut microbiota and short chain fatty acids in modulating energy harvest and fat partitioning in youth. J Clin Endocrinol Metab. 2016;101:4367-76. [ Links ]

42. Yuan X, Chen R, McCormick KL, Zhang Y, Lin X, Yang X. The role of the gut microbiota on the metabolic status of obese children. Microb Cell Fact. 2021;20:53. [ Links ]

43. Kim MH, Yun KE, Kim J, Park E, Chang Y, Ryu S, et al. Gut microbiota and metabolic health among overweight and obese individuals. Sci Rep. 2020;10:19417. [ Links ]

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author has this document.

FundingFacultad de Medicina, Universidad Nacional Autónoma de México, IBM Community.

Received: January 12, 2022; Accepted: May 13, 2022

* Correspondence: Ruth Gutiérrez-Aguilar. Email: ruthgutz@unam.mx and María E. Frigolet. Email: maruf.himfg@gmail.com

Conflicts of interest

The authors declare no conflict of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open access article under the CC BY-NC-ND license